Literature DB >> 33494787

Blocking drug efflux mechanisms facilitate genome engineering process in hypercellulolytic fungus, Penicillium funiculosum NCIM1228.

Nandita Pasari1,2, Tulika Sinha1, Anmoldeep Randhawa1,3, Mayank Gupta1,3, Anju M Nair1,3, Olusola A Ogunyewo1, Sandhya Verma2, Praveen Kumar Verma2, Syed Shams Yazdani4,5.   

Abstract

BACKGROUND: Penicillium funiculosum NCIM1228 is a non-model filamentous fungus that produces high-quality secretome for lignocellulosic biomass saccharification. Despite having desirable traits to be an industrial workhorse, P. funiculosum has been underestimated due to a lack of reliable genetic engineering tools. Tolerance towards common fungal antibiotics had been one of the major hindrances towards development of reliable transformation tools against the non-model fungi. In this study, we sought to understand the mechanism of drug tolerance of P. funiculosum and the provision to counter it. We then attempted to identify a robust method of transformation for genome engineering of this fungus.
RESULTS: Penicillium funiculosum showed a high degree of drug tolerance towards hygromycin, zeocin and nourseothricin, thereby hindering their use as selectable markers to obtain recombinant transformants. Transcriptome analysis suggested a high level expression of efflux pumps belonging to ABC and MFS family, especially when complex carbon was used in growth media. Antibiotic selection medium was optimized using a combination of efflux pump inhibitors and suitable carbon source to prevent drug tolerability. Protoplast-mediated and Agrobacterium-mediated transformation were attempted for identifying efficiencies of linear and circular DNA in performing genetic manipulation. After finding Ti-plasmid-based Agrobacterium-mediated transformation more suitable for P. funiculosum, we improvised the system to achieve random and homologous recombination-based gene integration and deletion, respectively. We found single-copy random integration of the T-DNA cassette and could achieve 60% efficiency in homologous recombination-based gene deletions. A faster, plasmid-free, and protoplast-based CRISPR/Cas9 gene-editing system was also developed for P. funiculosum. To show its utility in P. funiculosum, we deleted the gene coding for the most abundant cellulase Cellobiohydrolase I (CBH1) using a pair of sgRNA directed towards both ends of cbh1 open reading frame. Functional analysis of ∆cbh1 strain revealed its essentiality for the cellulolytic trait of P. funiculosum secretome.
CONCLUSIONS: In this study, we addressed drug tolerability of P. funiculosum and developed an optimized toolkit for its genome modification. Hence, we set the foundation for gene function analysis and further genetic improvements of P. funiculosum using both traditional and advanced methods.

Entities:  

Keywords:  Agrobacterium-mediated transformation; CRISPR/Cas9; Cellobiohydrolase I; Drug tolerance; Genome modification

Year:  2021        PMID: 33494787      PMCID: PMC7836482          DOI: 10.1186/s13068-021-01883-4

Source DB:  PubMed          Journal:  Biotechnol Biofuels        ISSN: 1754-6834            Impact factor:   6.040


  29 in total

Review 1.  Strategies for the transformation of filamentous fungi.

Authors:  B Ruiz-Díez
Journal:  J Appl Microbiol       Date:  2002       Impact factor: 3.772

2.  DNA-free genome editing in plants with preassembled CRISPR-Cas9 ribonucleoproteins.

Authors:  Je Wook Woo; Jungeun Kim; Soon Il Kwon; Claudia Corvalán; Seung Woo Cho; Hyeran Kim; Sang-Gyu Kim; Sang-Tae Kim; Sunghwa Choe; Jin-Soo Kim
Journal:  Nat Biotechnol       Date:  2015-10-19       Impact factor: 54.908

3.  Regulation of constitutively expressed and induced cutinase genes by different zinc finger transcription factors in Fusarium solani f. sp. pisi (Nectria haematococca).

Authors:  Daoxin Li; Tatiana Sirakova; Linda Rogers; William F Ettinger; P E Kolattukudy
Journal:  J Biol Chem       Date:  2001-12-26       Impact factor: 5.157

Review 4.  Mechanisms of Antifungal Drug Resistance.

Authors:  Leah E Cowen; Dominique Sanglard; Susan J Howard; P David Rogers; David S Perlin
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-10       Impact factor: 6.915

5.  Development of an unmarked gene deletion system for the filamentous fungi Aspergillus niger and Talaromyces versatilis.

Authors:  Stéphane Delmas; Agustina Llanos; Jean-Luc Parrou; Matthew Kokolski; Steven T Pullan; Lee Shunburne; David B Archer
Journal:  Appl Environ Microbiol       Date:  2014-03-28       Impact factor: 4.792

6.  Quantitative multiplexed profiling of Penicillium funiculosum secretome grown on polymeric cellulase inducers and glucose.

Authors:  Funso Emmanuel Ogunmolu; Inderjeet Kaur; Nandita Pasari; Mayank Gupta; Syed Shams Yazdani
Journal:  J Proteomics       Date:  2018-03-26       Impact factor: 4.044

7.  Polyethylene glycol (PEG)-mediated transformation in filamentous fungal pathogens.

Authors:  Zhaohui Liu; Timothy L Friesen
Journal:  Methods Mol Biol       Date:  2012

8.  A novel transformation system using a bleomycin resistance marker with chemosensitizers for Aspergillus oryzae.

Authors:  Satoshi Suzuki; Sawaki Tada; Mari Fukuoka; Hiroko Taketani; Yoshiki Tsukakoshi; Mayumi Matsushita; Kosuke Oda; Ken-Ichi Kusumoto; Yutaka Kashiwagi; Masanori Sugiyama
Journal:  Biochem Biophys Res Commun       Date:  2009-03-24       Impact factor: 3.575

9.  A Novel Cellobiohydrolase I (CBHI) from Penicillium digitatum: Production, Purification, and Characterization.

Authors:  Fabiane Cristina Dos Santos; Marco Aurelio Schuler de Oliveira; Flavio Augusto Vicente Seixas; Ione Parra Barbosa-Tessmann
Journal:  Appl Biochem Biotechnol       Date:  2020-05-06       Impact factor: 2.926

Review 10.  If looks could kill: Fungal macroscopic morphology and virulence.

Authors:  Caitlin H Kowalski; Robert A Cramer
Journal:  PLoS Pathog       Date:  2020-06-18       Impact factor: 6.823

View more
  1 in total

1.  Genome editing in Penicillium funiculosum using in vitro assembled CRISPR-Cas9 ribonucleoprotein complexes.

Authors:  Tulika Sinha; Syed Shams Yazdani
Journal:  STAR Protoc       Date:  2022-08-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.